Pharmaceuticals
LC Conditions
Column
Prodigy 5 µm C8 150 Å, LC Column 150 x 4.6 mm, Ea
Brand
Prodigy
Part No
00F-3301-E0
Phase Name
C8
Elution Type
Isocratic
Mobile Phase
A: 0.025 M Phosphate buffer, pH 2.2 w/ H3PO4
B: Acetonitrile
Gradient Profile
Step No.
Time(min)
%A
%B
1
0
85
15
Flow Rate
1.50 mL/min
Temperature
22°C
Detection
UV-Vis Abs.-Variable Wave.(UV) @ (22°C)
Detection Info
Sample Notes
SecurityGuard™ Guard Cartridge System extends column lifetime. - SecurityGuard Cartridges, C8 4 x 3.0mm, 10/Pk Part No.: AJ0-4290 - Holder Part No.: KJ0-4282
Order Items Used in This Application
- 1. Oxycodone
- 2. Aspirin
- 3. Salicylic acid
-OEChem-05081000432D<br><br> 44 48 0 1 0 0 0 0 0999 V2000<br> 2.2314 -0.4472 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.1561 -2.2171 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 -2.9021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 1.9022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.1607 -1.4511 0.0000 N 0 0 3 0 0 0 0 0 0 0 0 0<br> 3.6897 -0.9755 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0<br> 4.5133 -1.4511 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0<br> 5.3370 -0.9755 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0<br> 2.8660 -1.4511 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0<br> 4.2392 -0.2781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.6897 -0.0245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5133 -2.4021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.3370 -0.0245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.5918 -0.2781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5133 0.4511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.6897 -2.8777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 -2.4021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 0.4511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.8418 -2.1832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5133 1.4022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 1.4022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.6897 1.8777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 2.9021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.6284 -1.7740 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0496 -1.6875 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.3760 0.3266 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.6795 -0.0113 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.7254 -2.9848 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.1239 -2.2945 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.9476 -0.1321 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.5490 0.5581 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.1840 -0.0943 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4989 0.3349 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.2912 -3.3526 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.0882 -3.3526 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.2638 -2.8277 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3879 -2.6055 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.2641 -2.6371 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 7.2957 -1.7609 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.0503 1.7122 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.6897 2.4977 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.6200 2.9021 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 3.5222 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1.3800 2.9021 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1 9 1 0 0 0 0<br> 1 18 1 0 0 0 0<br> 7 2 1 1 0 0 0<br> 2 36 1 0 0 0 0<br> 3 17 2 0 0 0 0<br> 4 21 1 0 0 0 0<br> 4 23 1 0 0 0 0<br> 5 8 1 0 0 0 0<br> 5 14 1 0 0 0 0<br> 5 19 1 0 0 0 0<br> 6 7 1 0 0 0 0<br> 6 9 1 0 0 0 0<br> 6 10 1 1 0 0 0<br> 6 11 1 0 0 0 0<br> 7 8 1 0 0 0 0<br> 7 12 1 0 0 0 0<br> 8 13 1 0 0 0 0<br> 8 24 1 6 0 0 0<br> 9 17 1 0 0 0 0<br> 9 25 1 1 0 0 0<br> 10 14 1 0 0 0 0<br> 10 26 1 0 0 0 0<br> 10 27 1 0 0 0 0<br> 11 15 2 0 0 0 0<br> 11 18 1 0 0 0 0<br> 12 16 1 0 0 0 0<br> 12 28 1 0 0 0 0<br> 12 29 1 0 0 0 0<br> 13 15 1 0 0 0 0<br> 13 30 1 0 0 0 0<br> 13 31 1 0 0 0 0<br> 14 32 1 0 0 0 0<br> 14 33 1 0 0 0 0<br> 15 20 1 0 0 0 0<br> 16 17 1 0 0 0 0<br> 16 34 1 0 0 0 0<br> 16 35 1 0 0 0 0<br> 18 21 2 0 0 0 0<br> 19 37 1 0 0 0 0<br> 19 38 1 0 0 0 0<br> 19 39 1 0 0 0 0<br> 20 22 2 0 0 0 0<br> 20 40 1 0 0 0 0<br> 21 22 1 0 0 0 0<br> 22 41 1 0 0 0 0<br> 23 42 1 0 0 0 0<br> 23 43 1 0 0 0 0<br> 23 44 1 0 0 0 0<br>M END
Compound Name
Oxycodone
CID
5284603
Molecular Formula
C18H21NO4
Molecular Weight
315
No. Hydrogen Bond Acceptors
5
No. Hydrogen Bond Donors
1
Similar Applications
Reversed Phase
Fast Screening Method for 86 Forensic Analytes in Human Urine by LC-MS/MS
Luna 5 µm C18(2) 100 Å, LC Column 50 x 2 mm, Ea
25864
Reversed Phase
Extraction of Opiates in Human Serum Using Strata-X PRO and a Kinetex 2.6 µm Biphenyl LC Column
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 3.0 mm, Ea
25490
Reversed Phase
Pain Panel from Urine using Strata DE SLE and a Kinetex Biphenyl Core-Shell LC Column
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 2.1 mm, Ea
24555
Reversed Phase
7.5 min Pain Panel on Kinetex 2.6µm Biphenyl, 30x2.1mm ESI+
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 30 x 2.1 mm, Ea
23560
Reversed Phase
Drugs of Abuse by LCMS using Kinetex 1.7u Biphenyl 50x2.1mm
Kinetex 1.7 µm Biphenyl 100 Å, LC Column 50 x 2.1 mm, Ea
23445
Reversed Phase
Drugs of Abuse by LCMS using Kinetex 1.7u EVO C18 50x2.1mm
Kinetex 1.7 µm EVO C18 100 Å, LC Column 50 x 2.1 mm, Ea
23444
Reversed Phase
Drugs of Abuse by LCMS using Luna Omega 1.6u C18 50x2.1mm
Luna Omega 1.6µm C18 100Å, LC Column 50 x 2.1 mm, EA
23443
Reversed Phase
Fast Pain Panel ESI+
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 30 x 2.1 mm, Ea
23384
Improved Performance
ZB-5MSplus Drugs of Abuse
Zebron ZB-5MSplus, GC Cap. Column 30 m x 0.25 mm x 0.25 µm, EA
23258
Reversed Phase
Opiates at high pH using Kinetex 5u EVO C18 50 x 2.1 mm
Kinetex 5 µm EVO C18 100 Å, LC Column 50 x 2.1 mm, Ea
22715
Reversed Phase
Full Pain Panel using Kinetex 2.6u Biphenyl 50x2.1mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 2.1 mm, Ea
22122
Reversed Phase
Fast Pain Panel using Kinetex 2.6 u Biphenyl 50x3.0mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 3.0 mm, Ea
22121
Reversed Phase
Full Pain Panel using Kinetex 5um Biphenyl 50x3.0mm
Kinetex 5 µm Biphenyl 100 Å, LC Column 50 x 3.0 mm, Ea
22120
Reversed Phase
Pain Panel Opiates using Kinetex 2.6u Biphenyl 50x3.0mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 3.0 mm, Ea
22108
Reversed Phase
Full Pain Panel using Kinetex 2.6u Biphenyl 50x3.0mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 3.0 mm, Ea
22104
Reversed Phase
Opiates using Kinetex 2.6u Biphenyl 50x2.1mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 50 x 2.1 mm, Ea
21972
Reversed Phase
Pain Panel using Strata-X-Drug B and Kinetex Phenyl-Hexyl 2.6u 50x4.6mm
Kinetex 2.6 µm Phenyl-Hexyl 100 Å, LC Column 50 x 4.6 mm, Ea
20847
Reversed Phase
Pain Panel Opiates by LC/MS using Kinetex 2.6u C18 50x2.1mm
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
20692
Reversed Phase
Pain Panel/Drug Screening by LCMS using Kinetex 2.6u C18 50x3.0mm
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 3 mm, Ea
20689
Reversed Phase
Pain Panel Mix-41 in Human Urine on Luna 3u, PFP(2), 50x3 by LC-MS/MS
Luna 3 µm PFP(2) 100 Å, LC Column 50 x 3 mm, Ea
20594
Reversed Phase
LC/MS/MS of Extended Opiates from urine using Strata-X-Drug B on a Kinetex C18 2.6µm, 50x2.1mm
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19705
Reversed Phase
Pain Panel on Kinetex C18 2.6µm 50 x 2.1 mm by LC/MS
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19177
Reversed Phase
Pain Panel with and without sample focusing on Kinetex C18 2.6µm 50 x 2.1 mm by LC/MS
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
19167
Reversed Phase
NIDA-5 Extracted from Human Urine at Cutoff - Kinetex 2.6µm C18 50 x 2.1mm ID by LCMSMS
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
18851
Reversed Phase
Pain panel extracted from human urine at cutoff - Kinetex C18 2.6µm 50x2.1mm LCMSMS
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
18850
Reversed Phase
Extraction of Opiates-NIDA5 Using Strata X-C on Kinetex 2.6µm C18 50 x 2.1mm ID by LCMS
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
18846
Reversed Phase
Extraction of Healthcare Opiates using strata X-C on Kinetex 2.6µm C18 50 x 2.1mm ID by LC/MS
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
18716
Reversed Phase
Healthcare Opiates on Kinetex 2.6µm C18 50 x 2.1 mm ID by LC/MS
Kinetex 2.6 µm C18 100 Å, LC Column 50 x 2.1 mm, Ea
18715
Application Specific
Expanded healthcare opiates (propyl derivatives) from urine by Screen C on a ZB-Drug1
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
18200
Application Specific
Healthcare opiates (propyl derivatives) by MSD on a ZB-Drug1
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
18181
Healthcare Opiates from Urine by Screen C on a ZB-5MSi
17908
Application Specific
Healthcare Opiates from Urine by Screen C on a ZB-Drug-1
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
17907
Application Specific
Healthcare Opiates by MSD on a ZB-Drug1
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
17899
Opiates expanded run by MSD on a ZB-5MSi
16555
Standard
Opiates expanded run by MSD on a ZB-XLB
Zebron ZB-XLB, GC Cap. Column 30 m x 0.25 mm x 0.25 µm, Ea
16554
Standard
Opiates on ZB-5
Zebron ZB-5, GC Cap. Column 30 m x 0.25 mm x 0.25 µm, Ea
14788
Reversed Phase
Opiates on Synergi Max-RP
Synergi 4 µm Max-RP 80 Å, LC Column 150 x 4.6 mm, Ea
14253
Reversed Phase
Opiates on Synergi Polar-RP
Synergi 4 µm Polar-RP 80 Å, LC Column 150 x 4.6 mm, Ea
14252
Reversed Phase
Opiates on Synergi Hydro-RP
Synergi 4 µm Hydro-RP 80 Å, LC Column 150 x 4.6 mm, Ea
14251